Gregory Dale Kirk MD
Dual Primary Appointment in Medicine & Epidemiology; Joint Appointment in Oncology
Join to View Full Profile
1800 Orleans StreetBaltimore, MD 21287
Phone+1 410-955-5000
Fax+1 410-955-5001
Dr. Kirk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Gregory Kirk, MD, MPH, PhD is the Vice Dean for Research at the Johns Hopkins Bloomberg School of Public Health, and previously served as the Vice Chair for Clinical and Translational Research for the Department of Medicine in the Johns Hopkins School of Medicine. Dr. Kirk graduated from medical school at the University of Oklahoma and completed residency and fellowship training at Johns Hopkins, Georgetown University and the National Institutes of Health. He received his MPH and doctoral degrees in Epidemiology from Johns Hopkins, and now is a Professor in the Departments of Medicine, Epidemiology and Oncology.
Dr. Kirk’s research focuses on understanding and ameliorating the overlapping epidemics of HIV and non-communicable diseases (NCDs) globally. He leads an interdisciplinary group of epidemiologists, clinicians, biostatisticians and behavioral and laboratory scientists involved in a diverse research portfolio in US and international settings (Africa, the Caribbean, the Netherlands). He initiated an NHLBI-funded consortium of Baltimore-based cohorts to longitudinally evaluate chronic pulmonary complications of HIV (SHIELD; Study of HIV Infection in the Etiology of Lung Disease). With >2,500 participants followed with collection of detailed respiratory surveys, biospecimens, and spirometry for 12 years, SHIELD is among the largest and longest running prospective cohorts of lung disease focused on HIV. As Principal Investigator, Dr. Kirk has received >$50 million in NIH grant funding from 6 different NIH institutes. He has contributed to >275 peer-reviewed publications and is an elected Fellow of the Infectious Diseases Society of America, the American College of Epidemiology and American Society of Clinical Investigation. Board-certified in preventive medicine, internal medicine, and infectious diseases, Dr. Kirk maintains certification and continues clinical practice in infectious diseases at Johns Hopkins Hospital and Hopkins Bayview Medical Center.
Education & Training
Clinical Center at the National Institutes of HealthFellowship, Infectious Diseases @ NIAID, 2004
Johns Hopkins Bloomberg School of Public HealthResidency, Public Health and General Preventive Medicine, 1994 - 1997
University of Oklahoma College of MedicineClass of 1993- University of Oklahoma Health Sciences CenterInternship, Internal Medicine
MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine
Certifications & Licensure
DC State Medical License 1999 - Present
FL State Medical License 2024 - 2026
IL State Medical License 2021 - 2026
MD State Medical License 1994 - 2026
IN State Medical License 2024 - 2025
PA State Medical License 2004 - 2024
CO State Medical License 2022 - 2023
American Board of Internal Medicine Infectious Disease- Join now to see all
Clinical Trials
- Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV Start of enrollment: 2013 Sep 26
- Technology-Enhanced Peer Navigation to Improve IDUs' Engagement in HIV Care Start of enrollment: 2013 Sep 01
Publications & Presentations
PubMed
- Changes in the prevalence of non-AIDS conditions among hospitalized persons with HIV in the United States and Canada, 2008-2018.Thibaut Davy-Mendez, Sonia Napravnik, Brenna C Hogan, Joseph J Eron, Kelly A Gebo
Clinical Infectious Diseases. 2025-04-02 - Drug treatment and support service utilization amidst the COVID-19 pandemic among people who inject drugs in Baltimore, Maryland: An interrupted time-series analysis, ...Eshan U Patel, Jacqueline E Rudolph, Kenneth A Feder, Xianming Zhu, Jacqueline Astemborski
The International Journal on Drug Policy. 2025-04-01 - Individual Heterogeneity and Trends in Hepatitis C Infection Risk Among People Who Inject Drugs: A Longitudinal Analysis.Kyra H Grantz, Javier Cepeda, Jacqueline Astemborski, Gregory D Kirk, David L Thomas
Journal of Viral Hepatitis. 2025-04-01
Journal Articles
- The Association Between HIV Infection and Mitochondrial DNA Copy Number in Peripheral Blood: A Population-Based, Prospective Cohort StudyTodd T Brown, Shruti H Mehta, Gregory D Kirk, The Journal of Infectious Diseases
Press Mentions
Advancing Knowledge of HIV Impact on Hepatitis C Infection and Genes That May Thwart HCVFebruary 10th, 2016
Grant Support
- Leveraging HIV care infrastructure for implementation of context-adapted liver cancer comprehensive control strategies in Uganda: The LC3 StudyJOHNS HOPKINS UNIVERSITY2024–2029
- Leveraging HIV care infrastructure for implementation of context-adapted liver cancer comprehensive control strategies in Uganda: The LC3 StudyJOHNS HOPKINS UNIVERSITY2024–2029
- Leveraging HIV care infrastructure for implementation of context-adapted liver cancer comprehensive control strategies in Uganda: The LC3 StudyJOHNS HOPKINS UNIVERSITY2024–2029
- Leveraging HIV care infrastructure for implementation of context-adapted liver cancer comprehensive control strategies in Uganda: The LC3 StudyJOHNS HOPKINS UNIVERSITY2024–2029
- Leveraging HIV care infrastructure for implementation of context-adapted liver cancer comprehensive control strategies in Uganda: The LC3 StudyJOHNS HOPKINS UNIVERSITY2024–2029
- Baltimore Oral Epidemiology, Disease Effects, and HIV Evaluation Study (BEEHIVE)UNIVERSITY OF MARYLAND BALTIMORE2020–2026
- HIV and HCC in Africa: The H2A ConsortiumJOHNS HOPKINS UNIVERSITY2020–2025
- Study of HIV Infection in the Etiology of Lung Disease (SHIELD) AIR: Air Pollution Impact on Respiratory Health in HIVJOHNS HOPKINS UNIVERSITY2020–2025
- Study of HIV Infection in the Etiology of Lung Disease (SHIELD) AIR: Air Pollution Impact on Respiratory Health in HIVJOHNS HOPKINS UNIVERSITY2020–2025
- HIV and HCC in Africa: The H2A ConsortiumJOHNS HOPKINS UNIVERSITY2020–2025
- Study of HIV Infection in the Etiology of Lung Disease (SHIELD) AIR: Air Pollution Impact on Respiratory Health in HIVJOHNS HOPKINS UNIVERSITY2020–2025
- HIV and HCC in Africa: The H2A ConsortiumJOHNS HOPKINS UNIVERSITY2020–2025
- HIV and HCC in Africa: The H2A ConsortiumJOHNS HOPKINS UNIVERSITY2020–2025
- HIV and HCC in Africa: The H2A ConsortiumJOHNS HOPKINS UNIVERSITY2020–2025
- Study of HIV Infection in the Etiology of Lung Disease (SHIELD) AIR: Air Pollution Impact on Respiratory Health in HIVJOHNS HOPKINS UNIVERSITY2020–2025
- HIV and HCC in Africa: The H2A ConsortiumJOHNS HOPKINS UNIVERSITY2020–2025
- HIV and HCC in Africa: The H2A ConsortiumJOHNS HOPKINS UNIVERSITY2020–2025
- HIV and HCC in Africa: The H2A ConsortiumJOHNS HOPKINS UNIVERSITY2020–2025
- HIV and HCC in Africa: The H2A ConsortiumJOHNS HOPKINS UNIVERSITY2020–2025
- HIV and HCC in Africa: The H2A ConsortiumJOHNS HOPKINS UNIVERSITY2020–2025
- Study of HIV Infection in the Etiology of Lung Disease (SHIELD) AIR: Air Pollution Impact on Respiratory Health in HIVJOHNS HOPKINS UNIVERSITY2020–2025
- Johns Hopkins HIV and Heart, Lung, Blood & Sleep Disorders Training Program (H3TP)JOHNS HOPKINS UNIVERSITY2018–2025
- Pharmacogenomics of ART adherence and effectiveness in the ALIVE CohortJOHNS HOPKINS UNIVERSITY2018–2025
- AIDS Linked to the IntraVenous Experience (ALIVE)JOHNS HOPKINS UNIVERSITY2014–2024
- Natural History Of HIV Infection In Injection Drug UsersNational Institute On Drug Abuse2007–2011
- The Study Of HIV Infection In The Etiology Of Lung Disease (SHIELD)National Heart, Lung, And Blood Institute2007–2011
- Epidemiology And Mechanisms Of Accelerated Aging In HIV InfectionNational Institute Of Allergy And Infectious Diseases2009–2010
- REAL Time Methods For Quantifying Exposure To Illicit Drugs &Psychosocial StressNational Institute On Drug Abuse2007–2010
- Natural History Of HIV Infection In Injection Drug UsersNational Institute On Drug Abuse2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
